0
ARTICLE |

CARONAMIDE AND PENICILLIN: Title and subTitle BreakSerum Levels in Human Beings, Following Multiple Doses of the Drugs FREE

MANSON MEADS, M.D.; ROLAND V. LONG, M.D.; SHERMAN H. PACE, M.D.; GEORGE T. HARRELL, M.D.
[+] Author Affiliations

Dr. Meads is a Markle Scholar in Medicine.

This study was aided by a grant from the Antibiotic Study Section of the United States Public Health Service.


Winston-Salem, N. C.

From the Department of Internal Medicine, Bowman Gray School of Medicine of Wake Forest College and the North Carolina Baptist Hospital, Winston-Salem.


JAMA. 1948;138(12):874-877. doi:10.1001/jama.1948.02900120016004
Text Size: A A A
Published online

Numerous attempts have been made to increase the efficacy of penicillin in the treatment of infections by altering the rate of its absorption or excretion. Beyer and his associates have reported that caronamide (4′-carboxyphenylmethanesulfonanilide), though excreted only by the glomeruli, alters the specific renal tubular enzyme system responsible for the excretion of penicillin.1 The excretion of penicillin is delayed, so that a higher concentration may be maintained in the blood for more prolonged periods. Other investigators have confirmed the original reports on the penicillin-enhancing effect of caronamide and have noted that the drug is relatively nontoxic when administered over short periods of time.2

There is difference of opinion concerning the dose of caronamide necessary to maintain an effective concentration of penicillin in the blood. Direct information on the absorption and excretion of caronamide in human beings has been lacking, since practical methods of measuring the concentrations of the

REFERENCES

Beyer, K. H.:  New Concept of Competitive Inhibition of the Renal Tubular Excretion of Penicillin , Science 105: 94-95 ( (Jan. 24) ) 1947;.
Beyer, K. H.; Miller, A. K.; Russo, H. F.; Patch, E. A., and Verwey, W. F.:  The Inhibitory Effect of Caronamide on the Renal Elimination of Penicillin , Am. J. Physiol. 149: 355-368 ( (May) ) 1947;.
Beyer, K. H.; Russo, H. F.; Patch, E. A.; Tillson, E. K., and Shaner, G.:  Certain Pharmacologic Properties of 4′-Carboxyphenylmethanesulfonanilide (Caronamide), Including Its Effect on the Renal Clearance of Compounds Other Than Penicillin , J. Pharmacol. & Exper. Therap. 91: 272-287 ( (Nov.) ) 1947;.
Seeler, A. O.; Wilcox, C., and Finland, M.:  Enhancement of Blood Levels by Caronamide During Intramuscular Administration of Penicillin , J. Lab. & Clin. Med. 32: 807-817 ( (July) ) 1947;.
Strauss, E.; Richburg, P. L.; Saba, P. Z., and Alexander, J. E.:  Enhancement of Plasma Penicillin Concentrations by Caronamide and Sodium Benzoate , J. Lab. & Clin. Med. 32: 818-831 ( (July) ) 1947;.
Crosson, J. W.; Boger, W. P.; Shaw, C. C., and Miller, A. K.:  Caronamide for Increasing Penicillin Plasma Concentrations in Man , J. A. M. A. 134: 1528-1532 ( (Aug. 30) ) 1947;.
Shaw, C. C.; Boger, W. P.; Crossen, J. W.; Kemp W. W.; Ling, W. S. M., and Duncan, G. G.:  Enhancement of Penicillin Blood Levels in Man by Means of a New Compound, Caronamide , Am. J. Med. 3: 206-210 ( (Aug.) ) 1947;.
The penicillin used in this study was supplied by Wyeth, Inc., Philadelphia.
Sharpe and Dohme, Inc., Philadelphia, furnished the caronamide used in this study. Dr. William P. Boger, associate medical director, made available to us the results of several of his studies prior to their publication.
Ziegler, C., and Sprague, J. M.:  A Colorimetric Determination of Caronamide , J. Lab. & Clin. Med. 33: 96-100 ( (Jan.) ) 1948;.
Boger, W. P.; Kay, C. F.; Eisman, S. H., and Yoeman, E. E.:  Caronamide, a Compound That Inhibits Penicillin Excretion by the Renal Tubules, Applied to the Treatment of Subacute Bacterial Endocarditis , Am. J. M. Sc. 214: 493-502 ( (Nov.) ) 1947;.
Beyer, K. H.; McKinney, S. E.; Tillson, E. K., and Green, C. W.:  4′Carboxyphenylmethanesulfonanilide (Caronamide): Its Toxicologic Effects , J. Pharmacol. & Exper. Therap. 91: 263-271 ( (Nov.) ) 1947;.
Earle, D. P., Jr., and Brodie, B. B.:  The Renal Excretion of 4′-Carboxyphenylmethanesulfonanilide (Caronamide) , J. Pharmacol. & Exper. Therap. 91: 250-254 ( (Nov.) ) 1947;.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Beyer, K. H.:  New Concept of Competitive Inhibition of the Renal Tubular Excretion of Penicillin , Science 105: 94-95 ( (Jan. 24) ) 1947;.
Beyer, K. H.; Miller, A. K.; Russo, H. F.; Patch, E. A., and Verwey, W. F.:  The Inhibitory Effect of Caronamide on the Renal Elimination of Penicillin , Am. J. Physiol. 149: 355-368 ( (May) ) 1947;.
Beyer, K. H.; Russo, H. F.; Patch, E. A.; Tillson, E. K., and Shaner, G.:  Certain Pharmacologic Properties of 4′-Carboxyphenylmethanesulfonanilide (Caronamide), Including Its Effect on the Renal Clearance of Compounds Other Than Penicillin , J. Pharmacol. & Exper. Therap. 91: 272-287 ( (Nov.) ) 1947;.
Seeler, A. O.; Wilcox, C., and Finland, M.:  Enhancement of Blood Levels by Caronamide During Intramuscular Administration of Penicillin , J. Lab. & Clin. Med. 32: 807-817 ( (July) ) 1947;.
Strauss, E.; Richburg, P. L.; Saba, P. Z., and Alexander, J. E.:  Enhancement of Plasma Penicillin Concentrations by Caronamide and Sodium Benzoate , J. Lab. & Clin. Med. 32: 818-831 ( (July) ) 1947;.
Crosson, J. W.; Boger, W. P.; Shaw, C. C., and Miller, A. K.:  Caronamide for Increasing Penicillin Plasma Concentrations in Man , J. A. M. A. 134: 1528-1532 ( (Aug. 30) ) 1947;.
Shaw, C. C.; Boger, W. P.; Crossen, J. W.; Kemp W. W.; Ling, W. S. M., and Duncan, G. G.:  Enhancement of Penicillin Blood Levels in Man by Means of a New Compound, Caronamide , Am. J. Med. 3: 206-210 ( (Aug.) ) 1947;.
The penicillin used in this study was supplied by Wyeth, Inc., Philadelphia.
Sharpe and Dohme, Inc., Philadelphia, furnished the caronamide used in this study. Dr. William P. Boger, associate medical director, made available to us the results of several of his studies prior to their publication.
Ziegler, C., and Sprague, J. M.:  A Colorimetric Determination of Caronamide , J. Lab. & Clin. Med. 33: 96-100 ( (Jan.) ) 1948;.
Boger, W. P.; Kay, C. F.; Eisman, S. H., and Yoeman, E. E.:  Caronamide, a Compound That Inhibits Penicillin Excretion by the Renal Tubules, Applied to the Treatment of Subacute Bacterial Endocarditis , Am. J. M. Sc. 214: 493-502 ( (Nov.) ) 1947;.
Beyer, K. H.; McKinney, S. E.; Tillson, E. K., and Green, C. W.:  4′Carboxyphenylmethanesulfonanilide (Caronamide): Its Toxicologic Effects , J. Pharmacol. & Exper. Therap. 91: 263-271 ( (Nov.) ) 1947;.
Earle, D. P., Jr., and Brodie, B. B.:  The Renal Excretion of 4′-Carboxyphenylmethanesulfonanilide (Caronamide) , J. Pharmacol. & Exper. Therap. 91: 250-254 ( (Nov.) ) 1947;.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.